Showing 8341-8350 of 8692 results for "".
- Free Drug Samples May Influence Prescribing Habitshttps://practicaldermatology.com/news/20140417-free_drug_samples_may_influence_prescribing_habits/2459266/Results of a study published online on April 16 in JAMA Dermatology found that the availability of free medication samples in dermatology offices appears to change pr
- Dermatology Resident Survey Finds Practice Gaps in Patient Safetyhttps://practicaldermatology.com/news/20140417-dermatology_resident_survey_finds_practice_gaps_in_patient_safety/2459267/A 2012 survey-based study of 142 dermatology residents from 44 US and Canadian residency programs was conducted to identify the source of clinical practices among dermatology residents that affect patient safety and determine the best approach for overcomi
- Syneron Receives FDA Clearance to Market the Ultrashape System for Fat Cell Destructionhttps://practicaldermatology.com/news/20140414-syneron_receives_fda_clearance_to_market_the_ultrashape_system_for_fat_cell_destruction/2459273/
- SkinCeuticals Announces the Launch of its First US Flagship Locationhttps://practicaldermatology.com/news/20140414-skinceuticals_announces_the_launch_of_its_first_us_flagship_location/2459274/SkinCeuticals launched SkinCeuticals Advanced Clinical Spa with Manhattan Dermatology and Cosmetic Surgery, the first flagship location. An exclusive Integrated Skincare treatment menu has been created, featuring comprehensive offerings that range from clinical procedures to
- TetraLogic Acquires Shape Pharmaceuticals, Inc.https://practicaldermatology.com/news/20140407-tetralogic_acquires_shape_pharmaceuticals_inc/2459275/TetraLogic Pharmaceuticals Corporation has entered an agreement to acquire Shape Pharmaceuticals, a biotechnology company. Shape Pharmaceuticals is developing SHAPE, which is a tissue-targeted HDAC inhibitor in a topical gel formulation to treat stage IA-IIA Cutaneous T-Cell Lymphoma.
- Sun Pharma Acquires Ranbaxy in a $4 billion US Transactionhttps://practicaldermatology.com/news/20140407-sun_pharma_acquires_ranbaxy_in_a_4_billion_us__transaction/2459276/Sun Pharma will obtain 100% of Ranbaxy in an all stock transaction. The collaboration of these two pharmaceutical companies leads to the fifth largest generics company globally. There will be operations in 65 countries as well as 47 manufacturing facilities across 5 continents.
- Canfield Supports Operation Smile with VECTRA® 3Dhttps://practicaldermatology.com/news/20140401-canfield_supports_operation_smile_with_vectra_3d/2459282/For the dedicated doctors and staff of Operation Smile, overcoming challenges comes with the territory. Travelling the globe to some of the poorest places on earth, they have performed life changing surgeries for over 200,000 children afflicted with cleft lip, cleft palate and other facial deformit
- International Society of Hair Restoration Surgery Achieves ACCME Accreditation With Commendation for Educational Activitieshttps://practicaldermatology.com/news/20140401-international_society_of_hair_restoration_surgery__achieves_accme_accreditation_with_commendation_for_educational_activities/2459284/The International Society of Hair Restoration Surgery (ISHRS) – the largest international medical association of hair restoration surgeons – announced today that the Accreditation Council for Continuing Medical Education (ACCME) awarded the ISHRS Accreditation with Commendation for six years as a pr
- SGR Patch: AADA Disappointed By Congressional Actionhttps://practicaldermatology.com/news/20140401-sgr_patch_aada_disappointed_by_congressional_action/2459285/Statement from Brett M. Coldiron, MD, FAAD President, American Academy of Dermatology Association: The U.S. House of Representatives and Senate have averted a 24 percent cut in Medicare physician payments by agreeing to a one-year short-term measure (HR 4302) to maintain current Medicare payment r
- Image Skincare Releases Vectorize Technology™https://practicaldermatology.com/news/20140401-image_skincare_releases_vectorize_technology/2459287/Vectorize Technology has revolutionized ingredient delivery by enabling up to 100 treatments in a single application. Marc Ronert, M.D., Ph.D., President and Medical Director of Image Skincare said, "Vectorize Technology™ is a game-changer. It will revolutionize the way the world thinks a